12:23 05.07.2019

Ex-Kyivstar president Chernyshov joins Farmak's supervisory board

2 min read
Ex-Kyivstar president Chernyshov joins Farmak's supervisory board

PJSC Farmak pharmaceutical company (Kyiv) has introduced ex-president of Kyivstar Peter Chernyshov to the supervisory board of the company. Earlier Chernyshov headed Carlsberg in Ukraine.

"The supervisory board of Farmak made a decision to strengthen its membership by inviting a person with considerable experience in modern companies that have gone through intensive growth and development," the company said, citing Head of the supervisory board and the final beneficiary of the company Filia Zhebrovska.

According to her, taking into account the work on the generics market, Farmak's planning horizon is 5-10 years, so the company needs such specialists.

According to the release, the corresponding decision was approved by the Farmak shareholders at a meeting on July 4.

"I will work in the pharmaceutical industry. Of course, the most important thing is to understand how money is made in it and why some companies thrive and others do not. I will devote part of my time to Farmak, and I will even have a small office there," Chernyshov said, commenting on his appointment in Facebook.

He said that membership in the Farmak's supervisory board will not be his new permanent job. "I will not appear there every day and (most importantly) I will not lead anyone in the company. My main work will be participation in strategic projects of the company along with top management and other board members," the ex-president of Kyivstar said.

According to him, one of the reasons why he agreed to this position is the desire to work with Zhebrovska, who invited him to talk about a new position about a month ago.

"My goal is to help achieve a further strategic goal – to increase our presence in the European market, while at the same time contributing to the development in Ukraine as a serious R&D center and a leading domestic producer," Chernyshov said in the official press release.

AD
AD
AD
AD